We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
HIMS.MX

Price
820.18
Stock movement up
+21.61 (2.63%)
Company name
HIMS
Exchange
(MX
,
Currency
MXN
)
Sector
Consumer Defensive >
Household & Personal Products
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-31

DIVIDENDS

HIMS.MX does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open850.00
Daily high870.50
Daily low837.00
Daily Volume3K
All-time high1163.58
1y analyst estimate-
Beta-
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
HIMS.MXS&P500
Current price drop from All-time high-29.51%-1.10%
Highest price drop-29.51%-19.00%
Date of highest drop30 Oct 20258 Apr 2025
Avg drop from high-11.76%-2.76%
Avg time to new high6 days5 days
Max time to new high13 days89 days
COMPANY DETAILS
HIMS.MX (HIMS) company logo
Marketcap
-
Marketcap category
Small-cap
Description
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Employees
1637
Investor relations
-
CEO
Country
Mexico
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The company continues to have a strong growth outlook ahead.
November 9, 2025
HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
November 7, 2025
Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the party over?
November 7, 2025
Hims & Hers Health stock has seen its consensus analyst price target decrease from $47.42 to $46.67 per share. This shift comes as analysts weigh ongoing opportunities for growth against signals of em...
November 7, 2025
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
November 7, 2025
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
November 6, 2025
Novo Nordisk stock reversed higher Wednesday, though the Wegovy and Ozempic maker cut its sales outlook for the third time this year.
November 5, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 6.9% in the morning session after the company reported third-quarter 2025 results that showed strong revenue growth, even as its prof...
November 5, 2025
HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.
November 5, 2025
Hims & Hers Health (HIMS) has posted average annual earnings growth of 62.2% over the past five years and current forecasts call for the momentum to continue, with analysts expecting earnings to grow ...
November 5, 2025
Next page